Insider Shareholders with Direct Ownership of Zymeworks Inc. (ZYME)
This section provides a comprehensive overview of the insiders with direct ownership of Zymeworks Inc. (ZYME). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Zymeworks Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Lilly & Co Eli
> 10% Shareholder |
0 | 1,058,438 | 2,898,647 $38.3 Million | 18 |
Jan 31, 2019
Reduced 7.94%
|
|
Ali Tehrani
Chief Executive Officer |
65,368 | 62,052 | 260,325 $3.44 Million | 8 |
Jul 16, 2021
Reduced 13.66%
|
|
Anthony J. Polverino
Chief Scientific Officer |
7,976 | 1,048 | 36,407 $481,300 | 6 |
Jan 07, 2022
Added 0.2%
|
|
Neil A Klompas
Chief Operating Officer |
35,093 | 29,404 | 14,801 $195,669 | 10 |
Jul 05, 2022
Added 9.34%
|
|
Neil Josephson
Chief Medical Officer |
15,331 | 2,475 | 14,449 $191,015 | 6 |
Nov 10, 2022
Reduced 14.62%
|
|
Kathryn O'Driscoll
Chief People Officer |
7,704 | 1,354 | 6,350 $83,947 | 7 |
Jul 06, 2021
Added 7.43%
|
|
Diana Hausman
Chief Medical Officer |
27,707 | 26,048 | 5,377 $71,083 | 9 |
Mar 10, 2021
Reduced 16.31%
|
|
James Priour
Chief Commercial Officer |
2,776 | 950 | 2,513 $33,221 | 3 |
Jul 06, 2021
Added 16.87%
|